Research and Development

The Research and Development team at Asgard Therapeutics focuses on advancing innovative gene therapy techniques, specifically utilizing TrojanDC technology to enhance cancer immunotherapy. With a diverse skill set that includes expertise in cell reprogramming and preclinical pharmacology, the team collaborates on designing and executing experimental protocols, analyzing data, and translating findings into clinical applications to improve immune responses against cancer.